BoneScalpel® To Be Showcased at EUROSPINE 2016 Hands-On Workshop
FARMINGDALE, N.Y., Oct. 5, 2016 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic surgery and other surgical applications, announced its plans to participate in the Spine Society of Europe ("EUROSPINE") Annual Congress 2016 to be held in Berlin, Germany on October 5-7, 2016. Misonix will be exhibiting at EUROSPINE 2016 and will host a BoneScalpel hands-on workshop with a global audience of up to 50 spine surgeons on October 5th. The workshop entitled, Ultrasonic Techniques in Complex Spine will be facilitated by Fabrice Külling, MD, Deputy Chief of Spinal Surgery, Orthopedics and Traumatology from Kantonsspital in St. Gallen, Switzerland. The special workshop will provide surgeon attendees hands-on experience with the BoneScalpel ultrasonic bone-cutting instrument. They will learn how this technology can safely treat a wide variety of complex spine procedures. EUROSPINE 2016 is expected to draw more than 2,000 health professionals including doctors and spine surgeons from around the world who will gather to exchange information on the latest surgical challenges, treatment options, and treatment outcomes, as well as interact with colleagues. "Misonix is very pleased to be able to participate in EUROSPINE as this presents a special opportunity to engage a very large, worldwide audience of premier spine surgeons who will have an opportunity to experience the BoneScalpel first-hand and the benefits of its ultrasound technology," said Stavros Vizirgianakis, Interim CEO of Misonix. BoneScalpel with ultrasonic technology is increasingly being adopted by the spinal surgeon community for the purpose of making precise and safe bone cuts during challenging spine surgeries. Common surgical applications successfully treated with BoneScalpel have included deformity cases, laminectomies and transforaminal lumbar interbody fusions ("TLIF") all of which has helped lead to its increased adoption. "We are excited about the opportunity to showcase BoneScalpel to some of the foremost spine surgeons in the world today," said Scott Ludecker, Senior Vice President of Global Sales and Marketing. "BoneScalpel's ability to mitigate the potential for soft tissue collateral damage and minimize blood loss during complex spine surgeries are universally understood as being cornerstones for providing better patient outcomes. These are among the attributes that continue to attract the spinal surgeon community to the BoneScalpel." About Misonix Safe Harbor Statement
Logo - http://photos.prnewswire.com/prnh/20160201/328020LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bonescalpel-to-be-showcased-at-eurospine-2016-hands-on-workshop-300339746.html SOURCE Misonix, Inc. |
|